Feature, Freight News, Air, COVID-19 Noticeboard

GDP for WFS in Paris

[ November 2, 2020   //   ]

Worldwide Flight Services’ (WFS) Paris Charles de Gaulle pharma centre has been awarded Good Distribution Practice (GDP) certification. It follows the achievement of IATA CEIV Pharma certification at the start of 2020.

The GDP process by independent auditing specialists TÜV confirmed the facility’s temperature management capabilities and assessed and approved WFS’ pharma policy, including its internal auditing procedures, risk assessment and corrective/preventive measures, and critical supplier list.

Newly-appointed manager pharma at the WFS Center in Paris, Yann Favre, said: “As the world’s largest air cargo handler, WFS is already very actively involved in the safe and compliant handling of pharmaceutical shipments and medical devices across our international network. Gaining certifications for both IATA CEIV and GDP for our Pharma Centre in Paris means we have achieved the highest respective global standards recognised by the air cargo and pharmaceutical industries. This supports our objective to be the world’s leading air cargo handler for pharma shipments in terms of compliance and our able to safeguard product integrity.”  

As the only dedicated pharma handling facility owned by a ground handler at Paris Charles de Gaulle (CDG), the Centre already handles over 8,000 tonnes of temperature-controlled shipments a year for nearly 40 airline customers. WFS expects the Center to play an important role in the handling and distribution of Covid-19 vaccines for the population of France once these shipments begin.

In October, WFS announced the creation of a special Project Coldstream task force to safely and securely coordinate and manage its global response for the 16 billion doses of Covid vaccines expected to be transported by air.